Which patients would you treat with relugolix instead of injectable GnRH agonist therapy?

I would consider relugolix for patients with:

1. Intermediate-risk prostate cancer that needs a short course of androgen deprivation therapy

2. Patients with biochemical relapse that would benefit from a short course of ADT and salvage RT

2.5 Patient with pre-existing cardiac comorbidities

3. Potenti...